Aimei Health Technology Co., Ltd Ordinary Share (AFJK) - Total Assets
Based on the latest financial reports, Aimei Health Technology Co., Ltd Ordinary Share (AFJK) holds total assets worth $12.29 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore AFJK cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Aimei Health Technology Co., Ltd Ordinary Share - Total Assets Trend (2023–2025)
This chart illustrates how Aimei Health Technology Co., Ltd Ordinary Share's total assets have evolved over time, based on quarterly financial data. See Aimei Health Technology Co., Ltd Ordinar book value and equity for net asset value and shareholders' equity analysis.
Aimei Health Technology Co., Ltd Ordinary Share - Asset Composition Analysis
Current Asset Composition (December 2025)
Aimei Health Technology Co., Ltd Ordinary Share's total assets of $12.29 Million consist of 0.0% current assets and 100.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2023–2025)
This chart illustrates how Aimei Health Technology Co., Ltd Ordinary Share's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Aimei Health Technology Co., Ltd Ordinar.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aimei Health Technology Co., Ltd Ordinary Share's current assets represent 0.0% of total assets in 2025, a decrease from 0.8% in 2023.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2025, down from 0.8% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Aimei Health Technology Co., Ltd Ordinary Share Competitors by Total Assets
Key competitors of Aimei Health Technology Co., Ltd Ordinary Share based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Churchill Capital Corp XI
NASDAQ:CCXI
|
USA | $415.91 Million |
|
EQV Ventures Acquisition Corp. II
NYSE:EVAC
|
USA | $470.27 Million |
|
Republic Digital Acquisition Company Class A Ordinary Shares
NASDAQ:RDAG
|
USA | $311.78 Million |
|
FutureCrest Acquisition Corp.
NYSE:FCRS
|
USA | $293.89 Million |
|
Siddhi Acquisition Corp Class A Common stock
NASDAQ:SDHI
|
USA | $289.04 Million |
|
OneIM Acquisition Corp. Class A Ordinary Shares
NASDAQ:OIM
|
USA | $290.53 Million |
|
Oyster Enterprises II Acquisition Corp Class A Ordinary Shares
NASDAQ:OYSE
|
USA | $262.39 Million |
|
Pioneer Acquisition I Corp Class A Ordinary Shares
NASDAQ:PACH
|
USA | $256.83 Million |
Aimei Health Technology Co., Ltd Ordinary Share - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.01 | 0.00 | 0.05 |
| Quick Ratio | 0.01 | 0.00 | 0.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.50 Million | $-1.68 Million | $-203.57K |
Aimei Health Technology Co., Ltd Ordinary Share - Advanced Valuation Insights
This section examines the relationship between Aimei Health Technology Co., Ltd Ordinary Share's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.45 |
| Latest Market Cap to Assets Ratio | 3.15 |
| Asset Growth Rate (YoY) | -83.6% |
| Total Assets | $12.10 Million |
| Market Capitalization | $38.12 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Aimei Health Technology Co., Ltd Ordinary Share's assets at a significant premium (3.15x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Aimei Health Technology Co., Ltd Ordinary Share's assets decreased by 83.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Aimei Health Technology Co., Ltd Ordinary Share (2023–2025)
The table below shows the annual total assets of Aimei Health Technology Co., Ltd Ordinary Share from 2023 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $12.10 Million | -83.60% |
| 2024-12-31 | $73.81 Million | +4.75% |
| 2023-12-31 | $70.47 Million | -- |
About Aimei Health Technology Co., Ltd Ordinary Share
Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors… Read more